These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 6754496)

  • 21. [Mutagenicity of alkylnitrites in the Salmonella test].
    Quinto I
    Boll Soc Ital Biol Sper; 1980 Apr; 56(8):816-20. PubMed ID: 7004467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenic response of Ames strains cured of their inducible Fels 1 and Fels 2 prophages.
    Affolter M; Parent-Vaugeois C; Anderson A
    Cancer Res; 1983 Feb; 43(2):653-9. PubMed ID: 6336657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of pesticides containing 1,3-dichloropropene.
    De Lorenzo F; Degl'Innocenti S; Ruocco A; Silengo L; Cortese R
    Cancer Res; 1977 Jun; 37(6):1915-7. PubMed ID: 322862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of the mutagenic action (in the Ames system) of polycyclic aromatic hydrocarbons].
    Kobliakov VA; Tolcheev IuD; Khitrovo IA
    Vestn Akad Med Nauk SSSR; 1984; (5):25-9. PubMed ID: 6377730
    [No Abstract]   [Full Text] [Related]  

  • 26. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial mutation test on plafibride.
    Richold M; Jones E
    Arzneimittelforschung; 1981; 31(10a):1838-40. PubMed ID: 7032531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.
    Seino Y; Nagao M; Yahagi T; Hoshi A; Kawachi T; Sugimura T
    Cancer Res; 1978 Jul; 38(7):2148-56. PubMed ID: 350383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test].
    Khudoleĭ VV; Bartsch H; Malaveille C
    Vopr Onkol; 1981; 27(12):47-51. PubMed ID: 7034364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 32. Bovine bladder and liver cell and homogenate-mediated mutagenesis of Salmonella typhimurium with aromatic amines.
    Hix C; Oglesby L; MacNair P; Sieg M; Langenbach R
    Carcinogenesis; 1983 Nov; 4(11):1401-7. PubMed ID: 6357520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.
    Donahue EV; McCann J; Ames BN
    Cancer Res; 1978 Feb; 38(2):431-8. PubMed ID: 340030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella.
    Glauert HP; Reddy JK; Kennan WS; Sattler GL; Rao VS; Pitot HC
    Cancer Lett; 1984 Sep; 24(2):147-56. PubMed ID: 6383598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
    Ueno Y; Kubota K; Ito T; Nakamura Y
    Cancer Res; 1978 Mar; 38(3):536-42. PubMed ID: 342092
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J; Sakai Y; Nagase H
    Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Literature survey of bacterial, fungal, and Drosophila assay systems used in the evaluation of selected chemical compounds for mutagenic activity.
    Brown MM; Wassom JS; Malling HV; Shelby MD; Von Halle ES
    J Natl Cancer Inst; 1979 Apr; 62(4):841-71. PubMed ID: 155170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bacterial concentration on reversions induced in Salmonella typhimurium TA1538 by N-hydroxy-2-acetylaminofluorene.
    White GL; Beranek DT; Heflich RH
    Environ Mutagen; 1983; 5(4):565-75. PubMed ID: 6347679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotoxicity of N-acetylarylamines in the salmonella/hepatocyte system.
    Thorgeirsson SS; Erickson LC; Smith CL; Glowinski IB
    Environ Health Perspect; 1983 Mar; 49():141-5. PubMed ID: 6339222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-mutagenicity of 3-dimethylamino-psi-saccharin to Salmonella typhimurium.
    Ashby J; Callander RD
    Cancer Lett; 1983 Jul; 19(3):343-5. PubMed ID: 6349789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.